Biomarker prediction of clinical outcome in operable breast cancer patients treated with tamoxifen Emanuela ScarpiFranca De PaolaDino Amadori OriginalPaper Pages: 101 - 110
Immunohistochemical analysis of prostate specific antigen in breast cancer* Michael K. MillerPamela D. UngerIra J. Bleiweiss OriginalPaper Pages: 111 - 116
Rural-urban differences in radiation therapy for ductal carcinoma in-situ of the breast Mario SchootmanRebecca Aft OriginalPaper Pages: 117 - 125
Induction of apoptosis in mammary gland by a pure anti-estrogen ICI 182780 K. B. LimC. Y. NgH. Huynh OriginalPaper Pages: 127 - 138
Effect of α-difluoromethyl-ornithine on the expression and function of the epidermal growth factor receptor in human breast epithelial cells in culture Andrea ManniDaniel TroutLaurence Demers OriginalPaper Pages: 139 - 146
Biological considerations in locally advanced breast cancer treated with anthracycline-based neoadjuvant chemotherapy: thymidine labelling index is an independent indicator of clinical outcome Vahit OzmenNeslihan CabiogluTemel Dagoglu OriginalPaper Pages: 147 - 157
Premorbid body weight and its relations to primary tumour diameter in breast cancer patients; its dependence on estrogen and progesteron receptor status Bjørn Ove MæhleSteinar TretliThor Thorsen OriginalPaper Pages: 159 - 169
Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: a phase II study* Pier Franco ConteAlessandra GennariMario Del Tacca OriginalPaper Pages: 171 - 179
